Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Pfizer describes novel antiandrogen for castration-resistant prostate cancer

May 25, 2012

Preliminary phase I results show IW-001 to be well tolerated

May 24, 2012

Combination of Ad-rhE and chemotherapy proves beneficial in cancer patients

May 24, 2012

Oncolytic viral therapy shows potential as treatment for superficial tumors

May 24, 2012

New proton pump inhibitor shows promise in Japanese patients with GERD

May 24, 2012

An anti-M1 prime monoclonal antibody shows promising results in allergic rhinitis and asthma

May 24, 2012

Vivalis discloses novel agents for hepatitis C virus infection

May 24, 2012

ProINS-Tf fusion protein displays hypoglycemic activity

May 24, 2012

Human pharmacokinetic profile of RO-5458640 determined in monkeys

May 23, 2012

A new small molecule inhibits dermal inflammation in mouse models

May 23, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...